The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 2.80 (8.24%)
Spread: 0.70 (1.913%)
Open: 35.00
High: 37.30
Low: 35.00
Prev. Close: 34.00
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Financial Stocks Recover On Plans To Head South

Thu, 11th Sep 2014 11:14

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
Standard Life, up 1.8%. The Edinburgh headquartered savings and investment business is seeing a second consecutive day of recovery following the negative shock the company received from a couple of polls that showed a sharp rise of support for the "Yes" campaign in the run up to the Scottish independence referendum on September 18. On Wednesday Standard Life moved to reassure investors by saying that it could transfer parts of its business out of Scotland.

Royal Bank of Scotland, up 1.3%; Lloyds Banking Group, up 1.2%. The two part-government owned, and heavily Scotland exposed, banks are also recovering some recent weakness after saying they have made contingency plans to move their headquarters to London in the event of the Scottish people voting in favour of a split from the UK in next week's independence referendum. "While the scale of potential change is currently unclear, we have contingency plans in place which include the establishment of new legal entities in England," Lloyds said in a statement.
-------
FTSE 100 LOSERS
-------
Next, down 1.7%. Shares of the UK's biggest clothing retailer by market share have slipped despite a solid set of interim results. Investors were underwhelmed following the group's stellar run of late. Next reported a 19% rise in pretax profit to GBP324.2 million for the first half of the year, as revenue rose to GBP1.85 billion from GBP1.68 billion. The retailer cited a range of factors including the improving UK economy and much better summer weather, although it kept most of its full-year outlook unchanged, having already raised it twice this year. "Against lofty expectations, Next has had a stellar first half, but numbers are a little short of consensus," says Investec analyst Alistair Davies.

Tesco, down 0.8%. The supermarket giant has been outshone Thursday by Morrisons, which raised its interim dividend by 5%, along with delivering half-year results broadly in line with expectations. The delivery on planned shareholder returns has surprised some given that Tesco decided to slash its dividend by 75% less than two weeks ago due to the ongoing pressures in the UK grocery sector. Following recent share price weakness and the newly raised dividend payment, Shore Capital calculates that Morrison currently offers investors a particularly high dividend yield of almost 8%. This may have encouraged some investors to switch their supermarket holdings Wednesday. Morrison shares spiked as much as 4% in early trade, but are currently close to flat.
-------
FTSE 250 WINNERS
-------
Ocado, up 4.1%. The grocery delivery business has seen a strong jump in its share price after saying that its sales in the 12 weeks to August 10 were up 23% to GBP231.9 million, against GBP189.2 million a year earlier. Retail sales in the period were up 16% to GBP218.5 million against GBP189.2 million last year. Average orders per week increased by 17% to 163,000, against 139,000 last year, but average order size was down by 1.7% to GBP111.64 against GBP113.54 in the corresponding period in 2013. The company said its trading momentum was solid in the period, but Chief Executive Tim Steiner said the retail environment at the moment was "challenging", owing to the "increased level of promotional activity and price reductions across the industry".

RPC Group, up 2.6%. The packaging company saw its share rise after saying it has reached a deal to sell its rigid-sheet businesses in Italy and Belgium for an undisclosed amount. RPC said the deals, along with the sale of its disposables trading business Tedeco-Gizeh GmbH in Germany, mark the end of the divestment portion of its "Fitter for the Future" programme. The two deals are expected to conclude towards the end of this month.
-------
FTSE 250 LOSERS
-------
Home Retail Group, down 6.6%. The DIY and general merchants retailer reported a mixed quarterly update that recorded a ninth consecutive quarter of like-for-like sales growth for Argos, but tepid growth at its Homebase DIY unit as sales of seasonal goods fell short of last year. The group sounded a little cautious as it said it expects to report a benchmark profit in line with market expectations for the full year, in the range of GBP122 million and GBP135 million, although, as always, this will depend on how Argos performs over the key Christmas trading period. "To meet that target, we need Argos to continue its current run rate, with like-for-like sales broadly around 3% and margins close to flat," Chief Executive John Walden told journalists Thursday.

Ashmore Group, down 6.3%. The emerging markets asset manager reported a 34% drop in full-year pretax profit, as it came under pressure due to emerging-market volatility, lower performance fees and the strength of the pound. Ashmore made GBP170.3 million pretax profit in the year ended June 30, compared with GBP257.6 million last year. It said GBP46.0 million was due to foreign exchange translation, while GBP30.1 million was due to lower performance fees as a consequence of the market sell-off in May and June 2013 and continued volatility throughout the first half of the financial year.

William Hill, down 1.3%. The bookmaker has suffered a downgrading to Neutral From Overweight by analysts at HSBC. The bank also lowered its price target for William Hill to 365p from 385p, although that still suggests a small upside from Wednesday quote of 344.20p.

Green King, down 1.1%. The pub company has had its price target trimmed by Goldman Sachs to 860p from 890p, which comes with a Neutral recommendation. The shares closed Wednesday at 797.5p. The move from Goldman comes after Green King reported decidedly weak sales growth in the first 18 weeks of its financial year on Wednesday.
-------
AIM ALL-SHARE WINNERS
-------
Elektron Technology, up 12%. The Cambridge-based technology company, which makes things like switches, connectors and monitoring and control products for scientific, medical, industrial and commercial use, saw its shares rise Thursday after it reported an underlying operating profit for the first half of its financial year. The company reported a narrowed operating loss of GBP0.4 million for the six months to end-July, compared with a GBP2.1 million loss a year, thanks to its cost cutting and as exceptional items, including restructuring expenses, impairments and some finance items, fell to GBP1.0 million, from GBP2.1 million. Excluding those items, its underlying operating profit rose to GBP0.6 million, from nothing a year earlier.

Solo Oil, up 10%. The exploration group saw its shares rise after saying that interpretation of newly acquired seismic data has extended the potential of the Ntorya appraisal area within the Ruvuma license in Tanzania, and it had further increased its resource estimate for the license by combining the Ntorya discovery with the adjacent Likonde prospect. Main market listed Aminex is also significantly higher, up 21%. Aminex owns 75% of the Ruvuma license and is its operator, while Solo Oil PLC owns the rest.

Patagonia Gold, up 8.9%. The gold miner reported record production from its Lomada de Leiva mine in August, extracting 2,961 ounces at a cash cost of USD625 per ounce. The company also said it is on target to achieve its production target of 3,000 ounces of gold per month by the end of the third quarter.
-------
AIM ALL-SHARE LOSERS
-------
Stilo International, down 25%. Shares in the software company have plunged after the group reported its pretax profit and revenue fell in the first half, though the company said the fall would be offset in the second half and said it would pay an interim dividend. Stilo said pretax profit in the six months to June 30 nearly halved to GBP39,000, from GBP72,000 a year earlier, as revenue fell to GBP617,000 from GBP733,000 in 2013. Stilo said the fall in sales was down to a reduction in OmniMark content conversion software licence sales, which it expects to be offset by increased sales of its Migrate cloud XML content conversion service in the second half. The group also said it took a hit to the tune of GBP430,000 by adverse foreign exchange.

SpaceandPeople, down 13%. Shares in experiential marketing and media company have dropped after the company issued another profit warning for 2014 as a host of its businesses failed to meet performance expectations. The group said the first half of 2014 had proven challenging for its business and said that, while some of its operations have traded in line with the revised expectations, others have proved disappointing in comparison to the revised forecasts. The company is now forecasting pretax profit of GBP500,000 to GBP700,000 for the year, compared to the GBP2.3 million it made for the full year in 2013.

Futura Medical, down 11%. The healthcare company reported a widening of its pretax loss to GBP1.6 million in the first half of the year from GBP1.0 million in the previous year, as revenue fell to GBP2,262 from GBP320,513, and administrative and research and development costs rose. Futura said that its fund raising of GBP12 million in March would support the clinical development of its earlier-stage product portfolio towards commercialisation.
-------
By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
9 Aug 2023 12:07

IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.

Read more
18 Jul 2023 14:16

Futura Medical chair steps down, promotes non-executive director

(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down.

Read more
17 Jul 2023 09:13

Futura Medical agrees US licensing deal with Haleon for Med3000 gel

(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US.

Read more
17 Jul 2023 08:33

Futura Medical shares rise on ED licensing deal with Haleon

(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.

Read more
22 Jun 2023 14:45

IN BRIEF: Futura Medical hails continued momentum after Eroxon launch

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before.

Read more
15 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Friday 16 June 
Alpha Growth PLCAGM
Anglo-Eastern Plantations PLCAGM
Gulf Keystone Petroleum LtdAGM
John Lewis of Hungerford PLCGM re proposed cancellation of admission to trading on AIM
Tesco PLCAGM
Woodbois LtdAGM
Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM

 

Read more
12 Jun 2023 12:08

LONDON MARKET MIDDAY: Stocks firm as expected Fed pause still in doubt

(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision.

Read more
12 Jun 2023 10:13

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
12 Jun 2023 09:47

Futura shares jump after FDA approval for erectile dysfunction product

(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction.

Read more
18 Apr 2023 13:09

Futura's erection gel launched over-the-counter in the UK

(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.

Read more
18 Apr 2023 12:32

Futura launches Eroxon erectile dysfunction gel in UK stores

(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK.

Read more
5 Apr 2023 12:21

Futura Medical annual loss widens as eyes MED3000 progress

(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product.

Read more
29 Mar 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 30 March 
AO World PLCTrading Statement
Aquis Exchange PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
Ascential PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Chesnara PLCFull Year Results
Ebiquity PLCFull Year Results
Gattaca PLCHalf Year Results
Gresham House PLCFull Year Results
IGas Energy PLCFull Year Results
Impellam Group PLCFull Year Results
International Public Partnerships LtdFull Year Results
Ithaca Energy PLCFull Year Results
Microlise Group PLCFull Year Results
Moonpig Group PLCTrading Statement
PetroTal CorpFull Year Results
Renalytix PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Robinson PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
XLMedia PLCFull Year Results
Friday 31 March 
Amaroq Minerals LtdFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Computacenter PLCFull Year Results
Cooks Coffee Co LtdFull Year Results
CT Private Equity Trust PLCFull Year Results
Dignity PLCFull Year Results
ECO Animal Health Group PLCTrading Statement
HealthBeacon PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
James Halstead PLCHalf Year Results
Jaywing PLCTrading Statement
JPMorgan American Investment Trust PLCFull Year Results
Numis Corp PLCTrading Statement
Mothercare PLCTrading Statement
Quarto Group IncFull Year Results
UK Oil & Gas PLCFull Year Results
Vanquis Banking Group PLCFull Year Results
Monday 3 April 
Downing Renewables & Infrastructure Trust PLCFull Year Results
Elixirr International PLCFull Year Results
Fidelity Japan Trust PLCFull Year Results
Gaming Realms PLCFull Year Results
HydrogenOne Capital Growth PLCFull Year Results
N4 Pharma PLCFull Year Results
Renew Holdings PLCTrading Statement
Tracsis PLCHalf Year Results
Tuesday 4 April 
accesso Technology Group PLCFull Year Results
Anexo Group PLCTrading Statement
Epwin Group PLCFull Year Results
Merchants Trust PLCFull Year Results
Renewi PLCTrading Statement
Saga PLCFull Year Results
Wednesday 5 April 
EnQuest PLCFull Year Results
Futura Medical PLCFull Year Results
Hilton Food Group PLCFull Year Results
Lookers PLCFull Year Results
Lords Group Trading PLCFull Year Results
RS Group PLCTrading Statement
Topps Tiles PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Mar 2023 09:52

IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment

Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices.

Read more
14 Mar 2023 14:33

Futura Medical confirms Europe launch of MED3000; awaits FDA approval

(Alliance News) - Futura Medical PLC on Tuesday said its MED3000 product is now available online in Europe under the brand name Erexon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account